颌面部骨折伴严重口鼻出血流程化管理的效果:单中心经验
该单中心研究纳入2010至2020年国立成功大学医院创伤登记中面部简明损伤定级(AIS)>3且存在活动性口鼻出血的49例患者,比较血管造影组与非造影组、存活组与非存活组的特征。34例(69%)接受血管造影,其中21例行动脉栓塞;按本机构治疗流程,47例(96%)成功止血。血管造影组口服插管、GCS<9、头部AIS>3、ISS、CPR比例、死亡率及24小时内输注浓缩红细胞单位数均高于非造影组。非存活组低血压、CPR需求、头部AIS>3、颅底骨折、GCS<9、ISS及24小时内输注浓缩红细胞单位数均高于存活组,且血管造影比例更高;栓塞血管中上颌内动脉最常见(65%),缺氧性脑病占死亡的92%。结论认为流程导向管理可有效优化颌面部出血患者的结局。
要点
- 按本机构流程化管理,49例颌面部骨折伴活动性口鼻出血患者中47例(96%)成功止血。
- 34例(69%)接受血管造影,其中21例行动脉栓塞;栓塞血管中上颌内动脉最常见(65%)。
- 血管造影组较非造影组口服插管(97% vs. 53%,P<0.001)、GCS<9(79% vs. 27%,P<0.001)、头部AIS>3(65% vs. 13%,P=0.001)、CPR(41% vs. 0%,P=0.002)、死亡率(35% vs. 7%,P=0.043)及24小时内输注浓缩红细胞单位数(12 [6-20] vs. 2 [0-4],P<0.001)均更高。
- 非存活组较存活组低血压(62% vs. 8%,P<0.001)、CPR需求(85% vs. 8%,P<0.001)、头部AIS>3(92% vs. 33%,P<0.001)、颅底骨折(100% vs. 64%,P=0.011)、GCS<9(100% vs. 50%,P=0.003)、ISS(50 [43-57] vs. 29 [19-48],P<0.001)及24小时内输注浓缩红细胞单位数(18
- 非存活组血管造影比例高于存活组(92% vs. 61%,P=0.043);缺氧性脑病占死亡的92%。
适用人群与场景
- 2010至2020年国立成功大学医院创伤登记中面部简明损伤定级(AIS)>3且存在活动性口鼻出血的颌面部骨折患者。
诊断标准与关键阈值
- 纳入标准:面部简明损伤定级(AIS)评分>3且存在活动性口鼻出血。
处置流程与药物剂量
- 按本机构治疗流程进行管理,49例中47例(96%)成功止血。
- 34例(69%)接受血管造影,其中21例行动脉栓塞。
红旗征与不能漏的情况
- 非存活组中低血压(62% vs. 8%,P<0.001)、需CPR(85% vs. 8%,P<0.001)、头部AIS>3(92% vs. 33%,P<0.001)、颅底骨折(100% vs. 64%,P=0.011)、GCS<9(100% vs. 50%,P=0.003)比例更高。
- 缺氧性脑病占死亡的92%。
研究设计与关键结果
- 单中心回顾性研究,纳入49例面部AIS>3且活动性口鼻出血患者,34例(69%)接受血管造影,其中21例行动脉栓塞;47例(96%)按本机构治疗流程成功止血。
- 血管造影组 vs. 非造影组:口服插管97% vs. 53%(P<0.001),GCS<9 79% vs. 27%(P<0.001),头部AIS>3 65% vs. 13%(P=0.001),ISS 43 [33-50] vs. 22 [18-27](P<0.001),CPR 41% vs. 0%(P=0.002),死亡率35% vs. 7%(P=0.043),24小时内输注浓缩红细胞单位数12 [6-20] vs. 2 [0-4](P<0.001)。
- 非存活组 vs. 存活组:低血压62% vs. 8%(P<0.001),需CPR 85% vs. 8%(P<0.001),头部AIS>3 92% vs. 33%(P<0.001),颅底骨折100% vs. 64%(P=0.011),GCS<9 100% vs. 50%(P=0.003),ISS 50 [43-57] vs. 29 [19-48](P<0.001),24小时内输注浓缩红细胞单位数18 [13-22] vs. 6 [2-12](P=0.001),血管造影92% vs. 61%(P=0.043)。
- 栓塞血管中上颌内动脉最常见(65%);缺氧性脑病占死亡的92%。
证据类型、等级与局限
- 单中心回顾性研究,样本量49例。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,流程导向管理可有效优化颌面部出血患者的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Maxillofacial fractures can lead to massive oronasal bleeding; however, surgical hemostasis and packing procedures can be challenging owing to complex facial anatomy. Only a few studies investigated maxillofacial fractures with massive oronasal hemorrhage. However, thus far, no studies have reported a protocolized management approach for maxillofacial trauma from a single center. This study aimed to evaluate the effectiveness of protocolized management for maxillofacial fractures with oronasal bleeding.
METHODS: Patients were identified from the National Cheng University Hospital trauma registry from 2010 to 2020. We included patients with a face Abbreviated Injury Scale (AIS) score of > 3 and active oronasal bleeding. Patients' characteristics were compared between the angiography and non-angiography groups and between survivors and nonsurvivors.
RESULTS: Forty-nine patients were included. Among them, 34 (69%) underwent angiography, of whom 21 received arterial embolization. Forty-seven patients (96%) successfully achieved hemostasis by adhering to the treatment protocol at our institution. Compared with the non-angiography group, the angiography group had significantly more patients requiring oral intubation (97% vs. 53%, P < 0.001), Glasgow Coma Scale < 9 (GCS; 79% vs. 27%, P < 0.001), head AIS > 3 (65% vs. 13%, P = 0.001), higher Injury Severity Score (ISS; 43 [33-50] vs. 22 [18-27], P < 0.001), higher incidence of cardiopulmonary resuscitation (CPR; 41% vs. 0%, P = 0.002), higher mortality rate (35% vs. 7%, P = 0.043), and more units of packed red blood cells (PRBC) transfused within 24 h (12 [6-20] vs. 2 [0-4], P < 0.001). The nonsurvivor group had significantly more patients with hypotension (62% vs. 8%; P < 0.001), higher need for CPR (85% vs. 8%; P < 0.001), head AIS > 3 (92% vs. 33%; P < 0.001), skull base fracture (100% vs. 64%; P = 0.011), GCS score < 9 (100% vs. 50%; P = 0.003), higher ISS (50 [43-57] vs. 29 [19-48]; P < 0.001), and more units of PRBC transfused within 24 h (18 [13-22] vs. 6 [2-12]; P = 0.001) than the survivor group. More patients underwent angiography in the nonsurvivor group than in the survivor group (92% vs. 61%; P = 0.043). Among embolized vessels, the internal maxillary artery (65%) was the most common bleeding site. Hypoxic encephalopathy accounted for 92% of deaths.
CONCLUSIONS: Protocol-guided management effectively optimizes outcomes in patients with maxillofacial bleeding.
参考来源
- Wu FC, Hung KS, Lin YW, et al. Effectiveness of protocolized management for patients sustaining maxillofacial fracture with massive oronasal bleeding: a single-center experience. Scand J Trauma Resusc Emerg Med. 2022. PMID: 36411460. doi:10.1186/s13049-022-01047-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。